Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - NIAID
 More »

  • Obama Budget: More NIH Grants, Higher FDA User Fees
    However, NIH shifted about $67.9 million of the $194.5 million difference to its National Institute of Allergy and Infectious Diseases (NIAID), toward grants to establish ...
    4-11-2013
  • Inovio Wins $3.5M NIAID Grant to Advance Vaccine Device
    of Allergy and Infectious Diseases (NIAID) to advance development of a ... The NIAID grant follows a 2011 Small Business Innovation Research grant, for which Inovio ...
    4-10-2013
  • VaxInnate Wins $2.2M NIAID Grant for Dengue Vaccine
    of Allergy and Infectious Diseases (NIAID) to fund the development of a recombinant ... grant and look forward to working with NIAID to develop a vaccine to prevent dengue," ...
    4-4-2013
  • Fraunhofer Center Wins Up to $9.9M for Next-Gen Anthrax Vaccines
    The combined product "has the potential for an improved vaccine," Vidadi Yusibov, the Fraunhofer center's executive director, said in a statement. NIAID funding to support ...
    12-4-2012
  • Altravax Awarded $3.45M from NIAID for HIV-1 Vaccine Research
    of Allergy and Infectious Diseases (NIAID) toward research on antibody-inducing ... In 2010, NIAID awarded Altravax two Small Business Innovation Research grants totaling ...
    12-4-2012
  • HIV-AIDS Vaccines: Where Are We Now and Where Are We Heading...
    of Allergy and Infectious Disease (NIAID) announced the first encouraging results ... of Health (NIH), and in particular NIAID, are to be commended for their commitment ...
    12-3-2012
  • Stem Cells Save Teeth
    research grant from NIAID to fund evaluation and development of VSELs as a potential countermeasure against radiation exposure resulting from nuclear accident or terrorism. ...
    11-20-2012
  • Needle-Free Anthrax Vaccine Wins NIAID Contract
    Pfenex won a National Institute of Allergy and Infectious Diseases (NIAID) contract worth ... Under terms of the NIAID contract Pfenex could receive further funding of up to $22.9 ...
    10-17-2012
  • Funds Won for C. difficile-Targeted Antibiotic
    of Allergic and Infectious Diseases (NIAID) to fund continued preclinical development ... of Allergic and Infectious Diseases (NIAID) to fund continued preclinical development ...
    10-1-2012
  • GenVec Slashes Workforce by 30%
    GenVec won an approximately $590,000 Phase I SBIR grant from the NIAID in May to support its RSV vaccine program. A couple of months earlier the firm was awarded a $600,000 NIAID ...
    9-25-2012
  • Two Viral Links to Chronic Fatigue Debunked
    of Allergy and Infectious Diseases (NIAID) to commission its own study under the ... Lipkin said in a statement by Columbia. NIAID investigation followed controversy over ...
    9-18-2012
  • B Cell Secrets May Aid Flu Vaccine Design
    of Allergy and Infectious Diseases (NIAID) Vaccine Research Center have effectively ... most or all influenza virus strains," concludes NIAID director Anthony S. Fauci, M.D. Dr. ...
    8-30-2012
  • Diagnostics Platform Coming to Your Smartphone
    of Allergy and Infectious Diseases (NIAID) to fund a collaborative project focused ... being awarded $2.5 million by the NIAID to continue its work on the development of ...
    8-16-2012
  • NIAID Funds Malaria Vaccine Project
    on the project and founder and chairman of Antigen Discovery. "Such markers are a critically important component of vaccine development." NIAID Funds Malaria Vaccine Project
    8-13-2012
  • H1N1 Influenza vaccine manufacturers ramp up for October 15
    ... Crucell (CRXL): Crucell announced this week an NIH/NIAID contract worth up to $40.7M aimed at advancing the development of monoclonal antibodies for the treatment of seasonal and ...
    8-9-2012
  • More »

    Journal Articles

  • The NIAID Radiation Countermeasures Program Business Model
    Nathaniel Hafer, Bert W. Maidment, Richard J. Hatchett
    Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science
    The NIAID Radiation Countermeasures Program Business Model Biosecurity and Bioterrorism: ... The National Institute of Allergy and Infectious Diseases (NIAID) Radiation/Nuclear ...
  • Pilot Studies for Development of an HIV Subtype Panel for Surveillance...
    Mark Manak, Silvana Sina, Bharathi Anekella, Indira Hewlett, Eric Sanders-Buell, Viswanath Ragupathy, Jerome Kim, Marion Vermeulen, Susan L. Stramer, Ester Sabino, Piotr Grabarczyk, Nelson Michael, Sheila Peel, Patricia Garrett, Sodsai Tovanabutra, Michael P. Busch, Marco Schito
    AIDS Research and Human Retroviruses
    The continued global spread and evolution of HIV diversity poses significant challenges to diagnostics and vaccine strategies. NIAID partnered with the FDA, WRAIR, academia and ...
  • Implications of HIV PrEP Trials Results
    Fulvia Veronese, Peter Anton, Courtney V. Fletcher, Victor DeGruttola, Ian McGowan, Stephen Becker, Sheryl Zwerski, David Burns
    AIDS Research and Human Retroviruses
    Division of AIDS (DAIDS) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), and the Bill and Melinda Gates Foundation (BMGF) ...
  • Outcomes of a National Institute of Allergy and Infectious Diseases...
    Janet M. Young, Jim A. Turpin, Runa Musib, Opendra K. Sharma
    AIDS Research and Human Retroviruses
    The Workshop held on July 8-9, 2010 and supported by the Office of AIDS Research (OAR), the National Institute of Allergy and Infectious Diseases (NIAID), and the National ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll